SECsense Logo

Opus Genetics, Inc. SEC Form 8-K: Key Corporate Changes Revealed

$IRD
Form 8-K
Filed on: 2025-01-14
Source
Opus Genetics, Inc. SEC Form 8-K: Key Corporate Changes Revealed

Here are the key insights extracted from the provided financial report section:

  1. Filing Type: The document is an SEC Form 8-K, which is used to report unscheduled material events or corporate changes that are important to shareholders.
  2. Company Information:
  • Name: Opus Genetics, Inc.
  • CIK Number: 0001228627
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-34079
  • Employer Identification Number (EIN): 11-3516358
  • Address: 8 Davis Drive, Suite 220, Durham, NC 27709
  • Phone Number: 248-957-9024
  1. Date of Report: The report is dated January 13, 2025.
  2. Stock Information:
  • Type: Common Stock
  • Par Value: $0.0001 per share
  1. Financial Reporting Context: The report is framed within the context of a specific period, indicating that the information pertains to events or changes that occurred on January 13, 2025.
  2. XML Schema Reference: The filing references an XBRL schema with the file name "ird-20250113.xsd," indicating that the report is structured according to a specific data format used for financial reporting.

Overall, this section of the financial report provides a concise summary of the filing details for Opus Genetics, Inc., including essential company information, the nature of the report, and relevant stock details.